Loading...
You are here:  Home  >  Health  >  Current News

Mylan cuts forecasts on delays in new drugs, weak prices



(Reuters) - Mylan NV said on Wednesday that delays in launching key new drugs and eroding prices for generics in the United States will hurt its profitability this year and in 2018, sending its shares down more than 6 percent.


Other News

Britain seeks to fight the fat with soft drinks sugar levy LONDON (Reuters) - Britain on Thursday launched a strategy aimed at curbing childhood obesity by taxing companies which sell sugar-laced soft drinks...
Heart hospitalizations may spike days after snowstorms pass (Reuters Health) - Hospitalizations for heart problems may drop the day of a major snowstorm then climb above average in the aftermath, a U.S. study...
Novartis’ drug tops standard therapy in untreated lung cancer patients (Reuters) - Novartis AG said its cancer drug, Zykadia, was twice as effective as standard chemotherapy in slowing the progression of a rare form of ...

Found news:

Loading...

You might also like...

FDA teams with medical companies in Puerto Rico to tackle shortages

Read More →